IP Library Granted Patent US 8,401,655
Granted Patent B2
US 8,401,655 · App. 13/314,966 · Granted Mar 19, 2013

Stimulation design for neuromodulation

Inventor: Dirk De Ridder (Zelzate, BE)
Assignee: Advanced Neuromodulation Systems, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,401,655
App. No.
13/314,966
Granted
Mar 19, 2013
Kind
B2
Abstract

The present application relates to a new stimulation design which can be utilized to treat neurological conditions. The stimulation system produces a burst mode stimulation which alters the neuronal activity of the predetermined site, thereby treating the neurological condition or disorder. The burst stimulus comprises a plurality of groups of spike pulses having a maximum inter-spike interval of 100 milliseconds. The burst stimulus is separated by a substantially quiescent period of time between the plurality of groups of spike pulses. This inter-group interval may comprise a minimum of 5 seconds.

Claims (29)

1. A method of stimulating nerve tissue of a patient to treat a neurological disorder using an implantable pulse generator, the method comprising:

generating, by the implantable pulse generator, a burst stimulus that comprises a plurality of groups of spike pulses with a substantially quiescent period between each group in the plurality of groups, wherein (i) each group of spikes begins and ends at a reference amplitude level, (ii) the burst stimulus is maintained at or above an amplitude level greater than the reference amplitude level between spikes within a respective group of the plurality of spikes, (iii) each spike within each group is separated by a maximum inter-spike interval of 5 milliseconds, and (iv) each group is separated by a minimum inter-group interval of 20 milliseconds;

providing the burst stimulus from the implantable pulse generator to a medical lead; and

applying the burst stimulus to the nerve tissue of the patient via one or several electrodes of the medical lead.

2. The method of claim 1 further comprising:

controlling a number of spikes within a group of spikes of the burst stimulus according a parameter stored in the implantable pulse generator.

3. The method of claim 1 further comprising:

controlling a maximum spike amplitude according to a parameter stored in the implantable pulse generator.

4. The method of claim 1 further comprising:

controlling an inter-spike interval according to a parameter stored in the implantable pulse generator.

5. The method of claim 1 further comprising:

controlling an inter-group interval according to a parameter stored in the implantable pulse generator.

6. The method of claim 1 further comprising:

controlling a number of groups within the burst stimulus according to a parameter stored in the implantable pulse generator.

7. The method of claim 1 further comprising:

generating a hyperpolarizing pulse immediately before each group of spikes within the burst stimulus.

8. The method of claim 7 wherein an amplitude of the hyperpolarizing pulse is controlled by a parameter stored in the implantable pulse generator.

9. The method of claim 1 further comprising:

detecting, by the implantable pulse generator, hyperactivity within neural tissue using a sensor in the implantable pulse generator, wherein the generating the burst stimulus occurs in response to the detecting.

10. The method of claim 9 wherein the sensor is coupled to one or several electrodes of the medical lead.

11. The method of claim 1 wherein the amplitude level between spikes within an individual group is controllable by a parameter stored in the implantable pulse generator.

12. The method of claim 1 , wherein the neurological disorder is chronic pain.

13. The method of claim 1 , wherein the neurological disorder is hypertension, heart rhythm disorders or sleep apnea.

14. The method of claim 1 , wherein the neurological disorder is depression or obsessive-compulsive disorder.

15. The method of claim 1 , wherein the neurological disorder is obesity.

16. The method of claim 1 , wherein the neurological disorder is Parkinson's, epilepsy, tinnitus or phantom pain.

17. The method of claim 1 , wherein the neurological disorder is dystonia or chorea.

18. The method of claim 1 , wherein the nerve tissue is peripheral nerve tissue.

19. The method of claim 1 wherein the nerve tissue is brain tissue, spinal cord tissue, or brainstem tissue.

Continuity (4)
Continuation 12790505 · May 28, 2010
Continuation 11254465 · Oct 20, 2005
Provisional Application 60620781 · Oct 21, 2004
Related Publication 20120078319A1 · Mar 29, 2012